Beta-catenin pathway in ulcerative colitis-associated colorectal cancer and therapeutic implication.
Chen
Jiezhong
J
Huang
Xu-Feng
XF
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000378:metabolism*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D015179:Colorectal Neoplasms / Q000150:complications / Q000378:metabolism* / Q000517:prevention & control; D006801:Humans; D019804:Mesalamine / Q000494:pharmacology; D015398:Signal Transduction / Q000502:physiology*; D051176:beta Catenin / Q000378:metabolism*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D051176:beta Catenin; D019804:Mesalamine